ArticleFrontiers in oncology2023

Regorafenib alone or in combination with high/low-dose radiotherapy plus toripalimab as third-line treatment in patients with metastatic colorectal cancer: protocol for a prospective, randomized, controlled phase II clinical trial (SLOT).

Shujuan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.